Amprius Technologies (NYSE:AMPX) Shares Down 2% on Insider Selling

Shares of Amprius Technologies, Inc. (NYSE:AMPX) dropped 2% during mid-day trading on Friday following insider selling activity. The company traded as low as $17.63 and last traded at $17.9270. Approximately 8,794,506 shares traded hands during mid-day trading, a decline of 5% from the average daily volume of 9,252,353 shares. The stock had previously closed at $18.29.

Specifically, Director Wen Hsuan Hsieh sold 413,146 shares of the stock in a transaction that occurred on Thursday, March 12th. The stock was sold at an average price of $18.44, for a total value of $7,618,412.24. Following the completion of the transaction, the director directly owned 44,444 shares of the company’s stock, valued at approximately $819,547.36. This represents a 90.29% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Steven Chu sold 155,565 shares of Amprius Technologies stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $18.50, for a total value of $2,877,952.50. Following the transaction, the director directly owned 127,339 shares of the company’s stock, valued at approximately $2,355,771.50. The trade was a 54.99% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In other news, Director Steven Chu sold 166,632 shares of the business’s stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of $17.92, for a total value of $2,986,045.44. Following the sale, the director owned 127,339 shares in the company, valued at approximately $2,281,914.88. The trade was a 56.68% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Analysts Set New Price Targets

Several brokerages recently issued reports on AMPX. Roth Mkm reissued a “buy” rating and set a $20.00 price target (up from $16.00) on shares of Amprius Technologies in a report on Friday, March 6th. Cantor Fitzgerald upped their price objective on shares of Amprius Technologies from $16.00 to $20.00 and gave the stock an “overweight” rating in a research note on Friday, March 6th. William Blair reaffirmed an “outperform” rating on shares of Amprius Technologies in a report on Friday, March 6th. Oppenheimer reiterated an “outperform” rating and issued a $17.00 target price on shares of Amprius Technologies in a research note on Tuesday, December 23rd. Finally, Craig Hallum boosted their target price on Amprius Technologies from $17.00 to $21.00 and gave the stock a “buy” rating in a report on Friday, March 6th. Eight equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Amprius Technologies currently has a consensus rating of “Moderate Buy” and a consensus price target of $19.75.

Amprius Technologies News Roundup

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Northland Securities raised Q1 EPS estimates for AMPX, improving near-term earnings visibility and giving bulls a fundamental reason to buy. Q1 EPS Estimates for AMPX Increased by Northland Securities
• Positive Sentiment: Needham & Company reaffirmed its Buy rating on AMPX (and other brokers have raised targets or reiterated buys), adding analyst-level validation that can attract institutional and retail inflows. Needham & Company LLC Reaffirms Buy Rating for Amprius Technologies (NYSE:AMPX)
• Neutral Sentiment: Coverage summarizing Northland’s forecast for AMPX Q4 earnings provides modeling context for investors but is informational until tied to company guidance or additional upgrades. What is Northland Securities’ Forecast for AMPX Q4 Earnings?
• Negative Sentiment: Director Steven Chu sold 155,565 shares on March 12 at an average price of $18.50 (~$2.88M), cutting his holdings by roughly 55% — a large insider sale that can be interpreted as a negative signal and may create short-term downward pressure. SEC Filing: Steven Chu Sale (3/12)
• Negative Sentiment: On March 10 the same director sold another 166,632 shares at an average of $17.92 (~$2.99M). The consecutive large sales amplify the negative signaling despite possible non-operational reasons (tax, diversification). SEC Filing: Steven Chu Sale (3/10)

Amprius Technologies Stock Performance

The company has a market cap of $2.46 billion, a price-to-earnings ratio of -52.72 and a beta of 3.04. The firm’s 50-day moving average price is $11.88 and its 200 day moving average price is $11.07.

Amprius Technologies (NYSE:AMPX) last announced its quarterly earnings data on Wednesday, March 4th. The company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.03. Amprius Technologies had a negative net margin of 60.30% and a negative return on equity of 24.29%. The business had revenue of $25.23 million for the quarter, compared to analyst estimates of $22.91 million. Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. As a group, equities research analysts predict that Amprius Technologies, Inc. will post -0.45 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Voloridge Investment Management LLC bought a new position in shares of Amprius Technologies in the 3rd quarter worth $19,737,000. BNP Paribas Financial Markets increased its holdings in Amprius Technologies by 1,117.9% in the third quarter. BNP Paribas Financial Markets now owns 1,943,905 shares of the company’s stock valued at $20,450,000 after purchasing an additional 1,784,291 shares during the last quarter. Vanguard Group Inc. increased its holdings in Amprius Technologies by 37.0% in the third quarter. Vanguard Group Inc. now owns 6,512,620 shares of the company’s stock valued at $68,513,000 after purchasing an additional 1,757,395 shares during the last quarter. Norges Bank acquired a new position in Amprius Technologies in the fourth quarter valued at about $10,295,000. Finally, Invesco Ltd. lifted its stake in Amprius Technologies by 113.3% in the third quarter. Invesco Ltd. now owns 2,379,384 shares of the company’s stock valued at $25,031,000 after buying an additional 1,263,846 shares during the period. Institutional investors and hedge funds own 5.04% of the company’s stock.

About Amprius Technologies

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.